About | Free Trial

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Thomas Hecht?

Dr. Thomas Hecht

HHC Consulting

Bürgenstockhöhe 15

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Bürgenstockhöhe 15

Background Information

Employment History


Affimed N.V.


Cell Medica Limited


Hecht - HHC Consulting



Executive Chairman

Delenex Therapeutics AG

Vice President Marketing

Amgen Inc.

Co-Head of the Program for Bone Marrow Transplantation

University of Freiburg


Humabs BioMed SA

Chief Executive Officer
Cytos Biotechnology AG

Board Member
Kuros Biosciences Ltd

Board Member
Clovis Oncology, Inc.

Chairman of the Investors Advisory Board
German Kidney Foundation Support Society

Chairman of the Investors Advisory Board
Heidelberg Innovation

Chairman of the Supervisory Council
SuppreMol GmbH

Chairman of the Supervisory Board
R&D Directions





Web References (131 Total References)


www.affimed.com [cached]

Dr. Thomas Hecht, Chairman

Dr. Thomas Hecht, is chairman of Affimed's Supervisory Board since 2007 and Head of HHC consulting in Kuessnacht, Switzerland. He was previously Vice President Marketing at Amgen Europe, Lucerne, Switzerland. A seasoned manager and industry professional, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation, University of Freiburg, Germany.
Today, he provides services to the pharmaceutical industry in clinical development/ marketing and licensing strategies through HHC, a biopharmaceutical consulting company founded in 2002. He also serves as Chairman of the Boards of Cell Medica Ltd., Delenex AG and as Member of the Board of Humabs BioMed AG. In 2009, with the acquisition by Alcon, he stepped down from the Chairmanship of ESBATech AG; and in 2015, with the acquisition by Baxter International Inc., from his post as Chairman of the Supervisory Council of SuppreMol GmbH.

Affimed Therapeutics

www.affimed.com [cached]

Dr. Thomas Hecht (Chairman) Hecht Healthcare Consulting

Delenex Completes its Management Team - Delenex Therapeutics

www.delenex.com [cached]

Thomas Hecht, Chairman of the Board, commented: "Delenex is very pleased to welcome Thomas at its Management Board. Thomas brings all the clinical and strategic skills to Delenex which are needed to advance our products from preclinical into and through clinical stages of development.

Board of Directors - Delenex Therapeutics

www.delenex.com [cached]

Dr. Thomas Hecht Executive Chairman

Management - Delenex Therapeutics

www.delenex.com [cached]

Dr. Thomas Hecht

Dr. Thomas Hecht Executive Chairman

Similar Profiles

Other People with this Name

Other people with the name Hecht

Andrew Hecht
Garfield & Hecht P.C

Staci Hecht
Mahowald Insurance Agency

Janie Hecht
Laurentian Center

Sue Hecht
Flagler County Democratic Party

Phillip Hecht
Grapevine & Flower Mound

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory